Cell growth of BG-1 ovarian cancer cells is promoted by di-n-butyl phthalate and hexabromocyclododecane via upregulation of the cyclin D and cyclin-dependent kinase-4 genes

Molecular Medicine Reports

Volumn 5, Issue 3, 2012, Pages 761-766

  Park, Min Ah ^a   Hwang, Kyung A ^a   Lee, Hye Rim ^a   Yi, Bo Rim ^a   Jeung, Eui Bae ^a   Choi, Kyung Chul ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Cyclin D; Cyclin dependent kinase 4; Di n butyl phthalate; Endocrine disrupting chemicals; Estrogen; Hexaboromocyclododecane; Ovarian cancer cells

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE 4; ESTRADIOL; HEXABROMOCYCLODODECANE; PHTHALIC ACID DIBUTYL ESTER; PROTEIN P21;

ARTICLE; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PROTEIN EXPRESSION;

CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D; CYCLIN-DEPENDENT KINASE 4; DIBUTYL PHTHALATE; ENDOCRINE DISRUPTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROCARBONS, BROMINATED; OVARIAN NEOPLASMS; RECEPTORS, ESTROGEN; UP-REGULATION;

EID: 84863012441     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.712     Document Type: Article

References (37)

1. Choi KC and Jeung EB: The biomarker and endocrine disruptors in mammals. J Reprod Dev 49: 337-345, 2003.
2. Hwang KA, Park SH, Yi BR and Choi KC: Gene alterations of ovarian cancer cells expressing estrogen receptors by estrogen and bisphenol a using microarray analysis. Lab Anim Res 27: 99-107, 2011.
3. Gee RH, Charles A, Taylor N and Darbre PD: Oestrogenic and androgenic activity of triclosan in breast cancer cells. J Appl Toxicol 28: 78-91, 2008.
4. Bencko V: Human exposure to endocrine disrupters: carcinogenic risk assessment. Folia Histochem Cytobiol 39: 24-25, 2001.
5. Brevini TA, Zanetto SB and Cillo F: Effects of endocrine disruptors on developmental and reproductive functions. Curr Drug Targets Immune Endocr Metabol Disord 5: 1-10, 2005. (Pubitemid 40394300)
6. Thasni KA, Rojini G, Rakesh SN, Ratheeshkumar T, Babu MS, Srinivas G, Banerji A and Srinivas P: Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) status. Eur J Pharmacol 588: 158-164, 2008.
7. Xu Y, Yu RM, Zhang X, Murphy MB, Giesy JP, Lam MH, Lam PK, Wu RS and Yu H: Effects of PCBs and MeSO2-PCBs on adrenocortical steroidogenesis in H295R human adrenocortical carcinoma cells. Chemosphere 63: 772-784, 2006.
8. Kim YH, Kim SH, Lee HW, Chae HD, Kim CH and Kang BM: Increased viability of endometrial cells by in vitro treatment with di-(2-ethylhexyl) phthalate. Fertil Steril 94: 2413-2416, 2010.
9. Harris CA, Henttu P, Parker MG and Sumpter JP: The estrogenic activity of phthalate esters in vitro. Environ Health Perspect 105: 802-811, 1997. (Pubitemid 27487770)
10. Shanle EK and Xu W: Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action. Chem Res Toxicol 24: 6-19, 2011.
11. Ghisari M and Bonefeld-Jorgensen EC: Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions. Toxicol Lett 189: 67-77, 2009.
12. Daston GP, Cook JC and Kavlock RJ: Uncertainties for endocrine disrupters: our view on progress. Toxicol Sci 74: 245-252, 2003. (Pubitemid 36958292)
13. Ronisz D, Finne EF, Karlsson H and Forlin L: Effects of the brominated flame retardants hexabromocyclododecane (HBCDD), and tetrabromobisphenol A (TBBPA), on hepatic enzymes and other biomarkers in juvenile rainbow trout and feral eelpout. Aquat Toxicol 69: 229-245, 2004. (Pubitemid 38970049)
14. de Wit CA, Herzke D and Vorkamp K: Brominated flame retardants in the Arctic environment - trends and new candidates. Sci Total Environ 408: 2885-2918, 2010.
15. Ibhazehiebo K, Iwasaki T, Shimokawa N and Koibuchi N: 1,2,5,6,9,10-alphaHexabromocyclododecane (HBCD) impairs thyroid hormone-induced dendrite arborization of Purkinje cells and suppresses thyroid hormone receptor-mediated transcription. Cerebellum 10: 22-31, 2011.
16. Ibhazehiebo K, Iwasaki T, Xu M, Shimokawa N and Koibuchi N: Brain-derived neurotrophic factor (BDNF) ameliorates the suppression of thyroid hormone-induced granule cell neurite extension by hexabromocyclododecane (HBCD). Neurosci Lett 493: 1-7, 2011.
17. Colles A, Koppen G, Hanot V, Nelen V, Dewolf MC, Noel E, Malisch R, Kotz A, Kypke K, Biot P, Vinkx C and Schoeters G: Fourth WHO-coordinated survey of human milk for persistent organic pollutants (POPs): Belgian results. Chemosphere 73: 907-914, 2008.
18. Park SH, Kim KY, An BS, Choi JH, Jeung EB, Leung PC and Choi KC: Cell growth of ovarian cancer cells is stimulated by xenoestrogens through an estrogen-dependent pathway, but their stimulation of cell growth appears not to be involved in the activation of the mitogen-activated protein kinases ERK-1 and p38. J Reprod Dev 55: 23-29, 2009.
19. Yi BR, O SN, Kang NH, Hwang KA, Kim SU, Jeung EB, Kim YB, Heo GJ and Choi KC: Genetically engineered stem cells expressing cytosine deaminase and interferon-beta migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects. Int J Oncol 39: 833-839, 2011.
20. Yi BR, Kang NH, Hwang KA, Kim SU, Jeung EB and Choi KC: Antitumor therapeutic effects of cytosine deaminase and interferon-{beta} against endometrial cancer cells using genetically engineered stem cells in vitro. Anticancer Res 31: 2853-2861, 2011.
21. Ulbrich B and Stahlmann R: Developmental toxicity of polychlorinated biphenyls (PCBs): a systematic review of experimental data. Arch Toxicol 78: 252-268, 2004. (Pubitemid 38757118)
22. Stefanidou M, Maravelias C and Spiliopoulou C: Human exposure to endocrine disruptors and breast milk. Endocr MetabImmune Disord Drug Targets 9: 269-276, 2009.
23. Kashima H, Shiozawa T, Miyamoto T, Suzuki A, Uchikawa J, Kurai M and Konishi I: Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E. Endocr Relat Cancer 16: 113-122, 2009.
24. Choi JH, Lee KT and Leung PC: Estrogen receptor alpha pathway is involved in leptin-induced ovarian cancer cell growth. Carcinogenesis 32: 589-596, 2011.
25. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Ando S and Maggiolini M: G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67: 1859-1866, 2007. (Pubitemid 46383413)
26. Craig ZR, Wang W and Flaws JA: Endocrine disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling. Reproduction 142: 633-646, 2011.
27. Takamiya M, Lambard S and Huhtaniemi IT: Effect of bisphenol A on human chorionic gonadotrophin-stimulated gene expression of cultured mouse Leydig tumour cells. Reprod Toxicol 24: 265-275, 2007. (Pubitemid 47385098)
28. Mylchreest E, Wallace DG, Cattley RC and Foster PM: Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to Di (n-butyl) phthalate during late gestation. Toxicol Sci 55: 143-151, 2000. (Pubitemid 30252445)
29. Saffarini CM, Heger NE, Yamasaki H, Liu T, Hall SJ and Boekelheide K: Induction and persistence of abnormal testicular germ cells following gestational exposure to Di-(n-butyl) phthalate in p53-null mice. J Androl: August 25, 2011 (Epub ahead of print).
30. Kruger T, Long M and Bonefeld-Jorgensen EC: Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor. Toxicology 246: 112-123, 2008.
31. Dorosh A, Ded L, Elzeinova F and Peknicova J: Assessing oestrogenic effects of brominated flame retardants hexabromocyclododecane and tetrabromobisphenol A on MCF-7 cells. Folia Biol (Praha) 57: 35-39, 2011.
32. Aniagu SO, Williams TD and Chipman JK: Changes in gene expression and assessment of DNA methylation in primary human hepatocytes and HepG2 cells exposed to the environmental contaminants-Hexabromocyclododecane and 17-beta oestradiol. Toxicology 256: 143-151, 2009.
33. Eriksson P, Fischer C, Wallin M, Jakobsson E and Fredriksson A: Impaired behaviour, learning and memory, in adult mice neonatally exposed to hexabromocyclododecane (HBCDD). Environ Toxicol Pharmacol 21: 317-322, 2006.
34. Watanabe J, Kamata Y, Seo N, Okayasu I and Kuramoto H: Stimulatory effect of estrogen on the growth of endometrial cancer cells is regulated by cell-cycle regulators. J Steroid Biochem Mol Biol 107: 163-171, 2007. (Pubitemid 47380372)
35. Ptak A, Wrobel A and Gregoraszczuk EL: Effect of bisphenol-A on the expression of selected genes involved in cell cycle and apoptosis in the OVCAR-3 cell line. Toxicol Lett 202: 30-35, 2011.
36. Boehme K, Simon S and Mueller SO: Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol 236: 85-96, 2009.
37. Bredhult C, Backlin BM and Olovsson M: Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro. Reprod Toxicol 23: 550-559, 2007. (Pubitemid 46754749)